Taconic Biosciences

Taconic Biosciences

Private
Rensselaer, New YorkN/Ahttps://www.taconic.com/

Last Round

Buyout/LBO

Nov 1, 2022

Total Funding Raised

$199,999

Company Overview

Taconic Biosciences is a biotechnology company founded in 1952 that provides genetically engineered rodent models and services to the global biomedical research community.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Taconic Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Taconic Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBONov 1, 2022
Buyout/LBOFeb 7, 2019

Taconic Biosciences Investors

Notable investors and investment history

InvestorRounds
NIH RADxGrant
Avista Healthcare PartnersBuyout/LBO
Avista Capital PartnersBuyout/LBO
H.I.G. CapitalBuyout/LBO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2022

    Led by Avista Healthcare Partners.

  • Feb 7, 2019

    H.I.G. Capital led the buyout round.

Taconic Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Taconic Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Taconic Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersRensselaer, New York
Year Founded1952
Last FundingNov 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.